Risk of End-Stage Renal Disease Low With Type 1 Diabetes

Share this content:
Risk of End-Stage Renal Disease Low With Type 1 Diabetes
Risk of End-Stage Renal Disease Low With Type 1 Diabetes

THURSDAY, Nov. 9, 2017 (HealthDay News) -- Among patients with childhood-onset type 1 diabetes, there is a very low incidence of end-stage renal disease (ESRD), according to a Norwegian study published online October 12 in Diabetes Care.

Vibeke Gagnum, M.D., Ph.D. student, from Oslo University Hospital in Norway, and colleagues estimated the cumulative incidence of ESRD by linking the Norwegian Childhood Diabetes Registry to the Norwegian Renal Registry. Patients (7,871) were diagnosed during the periods 1973 to 1982 and 1989 to 2012 and followed through Nov. 30, 2015.

The researchers found that the mean time from diabetes diagnosis to the development of ESRD was 25.9 years. The cumulative incidence of ESRD was 0.7 percent at 20 years of diabetes duration, 2.9 percent at 30 years of duration, and 5.3 percent at 40 years of duration. Women had lower risk of developing ESRD compared to men (hazard ratio, 0.61), while ESRD risk was higher in individuals in whom diabetes had been diagnosed at 10 to 14 years of age versus those in whom it was diagnosed before 10 years of age (hazard ratio, 1.29).

"We report a very low incidence of ESRD among patients with childhood-onset diabetes in Norway," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Global Prevalence of Insufficient Activity 27.5 Percent

Global Prevalence of Insufficient Activity 27.5 Percent

Levels of insufficient physical activity stable between 2001, 2016; increase seen in high-income countries

HTN Tx Intensification Common Upon Discharge in U.S. Vets

HTN Tx Intensification Common Upon Discharge in U.S. ...

Fourteen percent of older adults admitted to hospital for non-cardiac conditions had intensification of tx

Quarterly Canakinumab Reduces Risk for Gout Attacks

Quarterly Canakinumab Reduces Risk for Gout Attacks

Doesn't affect serum uric acid levels over time, but targets interleukin-1β

is free, fast, and customized just for you!




Already a member?

Sign In Now »